Baudax Bio BXRX

$ 0.19 0.59%

Quarterly report 2023-Q3
added 11-20-2023

Baudax Bio Balance Sheet 2011-2024 | BXRX

Annual Balance Sheet Baudax Bio

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	1.86 M	-7.36 M	-21.2 M	-17 M	-	-	-	-	-	-	-	-
Long Term Debt	1.52 M	6.31 M	8.47 M	-	-	-	-	-	-	-	-	-
Long Term Debt Current	5.6 M	2.22 M	683 K	318 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	65.4 M	63.2 M	80.6 M	50.5 M	-	-	-	-	-	-
Total Current Liabilities	21.5 M	15.6 M	18.1 M	7.71 M	-	-	-	-	-	-	-	-
Total Liabilities	34.3 M	40.1 M	83.5 M	70.9 M	103 M	95.2 M	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-191 M	-132 M	-112 M	-36.2 M	-	-	-	-	-	-	-	-
Total Assets	10 M	53.3 M	68.7 M	54.2 M	35 M	32.8 M	-	-	-	-	-	-
Cash and Cash Equivalents	5.26 M	15.9 M	30.3 M	17.7 M	-	-	-	-	-	-	-	-
Book Value	-24.2 M	13.2 M	-14.8 M	-16.7 M	-68.3 M	-62.5 M	-	-	-	-	-	-
Total Shareholders Equity	-24.2 M	13.2 M	-14.8 M	-16.7 M	-68.3 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Baudax Bio

	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	1.43 M	1.52 M	2.18 M	5.1 M	5.1 M	6.31 M	6.91 M	7.52 M	8.18 M	8.47 M	8.47 M	8.47 M	8.47 M	455 K	520 K	455 K	455 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	21.8 M	23 M	14.4 M	34.3 M	37 M	36.6 M	39.1 M	40.1 M	82.2 M	78.4 M	76 M	83.5 M	83.5 M	83.5 M	83.5 M	70.9 M	70.9 M	70.9 M	70.9 M	103 M	103 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-189 M	-187 M	-180 M	-191 M	-182 M	-152 M	-145 M	-132 M	-162 M	-145 M	-129 M	-112 M	-112 M	-112 M	-112 M	-36.2 M	-36.2 M	-36.2 M	-36.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	20.6 M	21.3 M	7.06 M	10 M	17.5 M	40.8 M	48.8 M	53.3 M	61.5 M	73.8 M	75 M	68.7 M	68.7 M	68.7 M	68.7 M	54.2 M	54.2 M	54.2 M	54.2 M	35 M	35 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	363 K	1.42 M	3.8 M	5.26 M	5.65 M	5.21 M	11.5 M	15.9 M	14.8 M	25.4 M	30.7 M	30.3 M	30.3 M	30.3 M	30.3 M	17.7 M	17.7 M	17.7 M	17.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-1.2 M	-1.64 M	-7.31 M	-24.2 M	-19.5 M	4.23 M	9.74 M	13.2 M	-20.7 M	-4.57 M	-994 K	-14.8 M	-14.8 M	-14.8 M	-14.8 M	-16.7 M	-16.7 M	-16.7 M	-16.7 M	-68.3 M	-68.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-10.2 M	-10.7 M	-7.31 M	-24.2 M	-24.2 M	4.23 M	9.74 M	13.2 M	-20.7 M	-4.57 M	-994 K	-14.8 M	-14.8 M	-14.8 M	-14.8 M	-16.7 M	-16.7 M	-16.7 M	-16.7 M	-68.3 M	-	-	-	-62.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency